chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Limb discomfort
Clinical narrative: Unable to lift anything more than 2-3 pounds with my left arm; Pain in left arm after the first shot; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Unable to lift anything more than 2-3 pounds with my left arm) and INJECTION SITE PAIN (Pain in left arm after the first shot) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No medical history was provided by the reporter. .  Concomitant products included ATORVASTATIN, VORTIOXETINE and CALCITONIN for an unknown indication.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced LIMB DISCOMFORT (Unable to lift anything more than 2-3 pounds with my left arm) and INJECTION SITE PAIN (Pain in left arm after the first shot). On 06-Jan-2021, LIMB DISCOMFORT (Unable to lift anything more than 2-3 pounds with my left arm) and INJECTION SITE PAIN (Pain in left arm after the first shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to MOD21-049310 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow up received on 03-May-2021 contains non-significant information: updated reporter information
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Redness around the injection site; Itchiness at the injection site; Warm to touch at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to touch at the injection site), VACCINATION SITE ERYTHEMA (Redness around the injection site) and VACCINATION SITE PRURITUS (Itchiness at the injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to touch at the injection site) and VACCINATION SITE PRURITUS (Itchiness at the injection site). On 09-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness around the injection site). At the time of the report, VACCINATION SITE WARMTH (Warm to touch at the injection site), VACCINATION SITE ERYTHEMA (Redness around the injection site) and VACCINATION SITE PRURITUS (Itchiness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other concomitant products included medications for blood pressure and diabetes. Treatment information was not provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea
Clinical narrative: fatigue; Nauseous; extreme headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nauseous), HEADACHE (extreme headache) and FATIGUE (fatigue) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included Brain tumor (Experience regular headache).    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced NAUSEA (Nauseous) and HEADACHE (extreme headache). On 09-Mar-2021, the patient experienced FATIGUE (fatigue). At the time of the report, NAUSEA (Nauseous) outcome was unknown and HEADACHE (extreme headache) and FATIGUE (fatigue) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient states that her headache was extreme to an extent it dwarfed her tumor headache and it was different. On 10-Mar-2021, her headache and fatigue seemed to be improving. Concomitant medications were not reported. Treatment information in response to events was not provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Unable to get 2nd dose due to a snowstrom. More than 36 days have passed since first shot; A spontaneous report was received from a consumer concerning a 89-years-old female patient who received Moderna's COVID-19 vaccine(mRNA-1273) and experienced unable to get 2nd dose due to a snowstorm. More than 36 days have passed since first shot/missed dose.  The patient's medical history provided was not reported. No relevant concomitant medication was reported.  On 22 Jan 2020, prior to onset of the event, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 029L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  The patient was unable to get second dose scheduled on 19 Feb 2021, due to a snowstorm. The patient informed that more than 36 days passed since first dose. No treatment information was provided.  Action taken with mRNA-1273  in response to the event  was not reported.  The outcome of the event unable to get 2nd dose due to a snowstorm. More than 36 days have passed since first shot was considered recovered.; Reporter's Comments: This report refers to a case of Product dose omission issue for mRNA-1273, lot #unknown with no associated AEs.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain in the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Pain in the injection site). At the time of the report, VACCINATION SITE PAIN (Pain in the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Influenza like illness, Pyrexia, Rash macular
Clinical narrative: Left arm hot and red at injection site; Red blotches on chest and cheeks like sunburn; Flu like feeling; Left arm hot and red at injection site; Fever; chills; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Left arm hot and red at injection site), RASH MACULAR (Red blotches on chest and cheeks like sunburn), INFLUENZA LIKE ILLNESS (Flu like feeling), VACCINATION SITE ERYTHEMA (Left arm hot and red at injection site) and PYREXIA (Fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Left arm hot and red at injection site), RASH MACULAR (Red blotches on chest and cheeks like sunburn), INFLUENZA LIKE ILLNESS (Flu like feeling), VACCINATION SITE ERYTHEMA (Left arm hot and red at injection site), PYREXIA (Fever), CHILLS (chills) and FATIGUE (Very tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Left arm hot and red at injection site), RASH MACULAR (Red blotches on chest and cheeks like sunburn), INFLUENZA LIKE ILLNESS (Flu like feeling), VACCINATION SITE ERYTHEMA (Left arm hot and red at injection site), PYREXIA (Fever), CHILLS (chills) and FATIGUE (Very tired) outcome was unknown.            Concomitant medications were not reported. Patient took Tylenol and Benadryl to relieve her symptoms.  Action taken with mRNA-123 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: Left arm hot and red at injection site; Red blotches on chest and cheeks like sunburn; Flu like feeling; Left arm hot and red at injection site; Fever; chills; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Left arm hot and red at injection site), RASH MACULAR (Red blotches on chest and cheeks like sunburn), INFLUENZA LIKE ILLNESS (Flu like feeling), VACCINATION SITE ERYTHEMA (Left arm hot and red at injection site) and PYREXIA (Fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Left arm hot and red at injection site), RASH MACULAR (Red blotches on chest and cheeks like sunburn), INFLUENZA LIKE ILLNESS (Flu like feeling), VACCINATION SITE ERYTHEMA (Left arm hot and red at injection site), PYREXIA (Fever), CHILLS (chills) and FATIGUE (Very tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Left arm hot and red at injection site), RASH MACULAR (Red blotches on chest and cheeks like sunburn), INFLUENZA LIKE ILLNESS (Flu like feeling), VACCINATION SITE ERYTHEMA (Left arm hot and red at injection site), PYREXIA (Fever), CHILLS (chills) and FATIGUE (Very tired) outcome was unknown.            Concomitant medications were not reported. Patient took Tylenol and Benadryl to relieve her symptoms.  Action taken with mRNA-123 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Depressed mood, Dizziness, Feeling abnormal, Pain in extremity
Clinical narrative: Soreness of arm; Collapsed completely; feeling so dizzy that she went to sleep; Noose down; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Mar-2021 and was forwarded to Moderna on 10-Mar-2021.    This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Mar-2021 and was forwarded to Moderna on 10-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness of arm), FEELING ABNORMAL (Collapsed completely), DIZZINESS (feeling so dizzy that she went to sleep) and DEPRESSED MOOD (Noose down) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced PAIN IN EXTREMITY (Soreness of arm), FEELING ABNORMAL (Collapsed completely), DIZZINESS (feeling so dizzy that she went to sleep) and DEPRESSED MOOD (Noose down). At the time of the report, PAIN IN EXTREMITY (Soreness of arm), FEELING ABNORMAL (Collapsed completely), DIZZINESS (feeling so dizzy that she went to sleep) and DEPRESSED MOOD (Noose down) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow-up information received on 21-JUN-2021, contains no new information.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal sensation in eye, Adverse reaction, Asthenia, Body temperature, Body temperature increased
Clinical narrative: worst reaction; temp went up to 101.8; weak; eyes were bothering me; light would bother them too; just like the COVID over again; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (worst reaction), BODY TEMPERATURE INCREASED (temp went up to 101.8), ASTHENIA (weak), ABNORMAL SENSATION IN EYE (eyes were bothering me) and PHOTOPHOBIA (light would bother them too) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced ADVERSE REACTION (worst reaction), BODY TEMPERATURE INCREASED (temp went up to 101.8), ASTHENIA (weak), ABNORMAL SENSATION IN EYE (eyes were bothering me), PHOTOPHOBIA (light would bother them too) and COVID-19 (just like the COVID over again). At the time of the report, ADVERSE REACTION (worst reaction), BODY TEMPERATURE INCREASED (temp went up to 101.8), ASTHENIA (weak), ABNORMAL SENSATION IN EYE (eyes were bothering me), PHOTOPHOBIA (light would bother them too) and COVID-19 (just like the COVID over again) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive. On 09-Mar-2021, Body temperature: 101.8 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Treatment information was not provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Photophobia, SARS-CoV-2 test
Clinical narrative: worst reaction; temp went up to 101.8; weak; eyes were bothering me; light would bother them too; just like the COVID over again; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (worst reaction), BODY TEMPERATURE INCREASED (temp went up to 101.8), ASTHENIA (weak), ABNORMAL SENSATION IN EYE (eyes were bothering me) and PHOTOPHOBIA (light would bother them too) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced ADVERSE REACTION (worst reaction), BODY TEMPERATURE INCREASED (temp went up to 101.8), ASTHENIA (weak), ABNORMAL SENSATION IN EYE (eyes were bothering me), PHOTOPHOBIA (light would bother them too) and COVID-19 (just like the COVID over again). At the time of the report, ADVERSE REACTION (worst reaction), BODY TEMPERATURE INCREASED (temp went up to 101.8), ASTHENIA (weak), ABNORMAL SENSATION IN EYE (eyes were bothering me), PHOTOPHOBIA (light would bother them too) and COVID-19 (just like the COVID over again) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive. On 09-Mar-2021, Body temperature: 101.8 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Treatment information was not provided.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: nickel sized purple bruised at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (nickel sized purple bruised at the injection site) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (nickel sized purple bruised at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (nickel sized purple bruised at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment information in response to events was not provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Hyperventilation
Clinical narrative: back pain on her left side; breath; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain on her left side) and HYPERVENTILATION (breath) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced BACK PAIN (back pain on her left side) and HYPERVENTILATION (breath). At the time of the report, BACK PAIN (back pain on her left side) and HYPERVENTILATION (breath) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment information in response to events was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Vaccination site pain
Clinical narrative: Flu like symptoms; Sore arm at the vaccination site; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) and VACCINATION SITE PAIN (Sore arm at the vaccination site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms) and VACCINATION SITE PAIN (Sore arm at the vaccination site). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) and VACCINATION SITE PAIN (Sore arm at the vaccination site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site hypoaesthesia
Clinical narrative: numbness around injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HYPOAESTHESIA (numbness around injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included AMLODIPINE and ATORVASTATIN CALCIUM for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE HYPOAESTHESIA (numbness around injection site). At the time of the report, VACCINATION SITE HYPOAESTHESIA (numbness around injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment medication were reported.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Event outcome updated.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: bad headache; arm got so sore she cannot hardly move it  from shoulder to elbow; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of MYALGIA (arm got so sore she cannot hardly move it  from shoulder to elbow) and HEADACHE (bad headache) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Peripheral arterial disease.    On 11-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced MYALGIA (arm got so sore she cannot hardly move it  from shoulder to elbow). On an unknown date, the patient experienced HEADACHE (bad headache). At the time of the report, MYALGIA (arm got so sore she cannot hardly move it  from shoulder to elbow) had not resolved and HEADACHE (bad headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include two types of blood thinners used for unknown indication. Patient was told to apply heat and rub pain relievers, but they did not help.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: discomfort from swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (discomfort from swollen lymph nodes) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced LYMPHADENOPATHY (discomfort from swollen lymph nodes). At the time of the report, LYMPHADENOPATHY (discomfort from swollen lymph nodes) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment information was not provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Chills, Fatigue, Headache, Pain in extremity
Clinical narrative: The injection site was red for a while; Her arm hurt a little (L arm); Arm is swollen (L arm); Her armpits and the right arm began to hurt; Headache; Cold (chills); General tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Her arm hurt a little (L arm)), PERIPHERAL SWELLING (Arm is swollen (L arm)), AXILLARY PAIN (Her armpits and the right arm began to hurt), HEADACHE (Headache) and CHILLS (Cold (chills)) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMINS NOS for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced FATIGUE (General tiredness). On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (Her arm hurt a little (L arm)), PERIPHERAL SWELLING (Arm is swollen (L arm)), AXILLARY PAIN (Her armpits and the right arm began to hurt), HEADACHE (Headache) and CHILLS (Cold (chills)). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (The injection site was red for a while). At the time of the report, PAIN IN EXTREMITY (Her arm hurt a little (L arm)), PERIPHERAL SWELLING (Arm is swollen (L arm)), AXILLARY PAIN (Her armpits and the right arm began to hurt), HEADACHE (Headache), CHILLS (Cold (chills)), FATIGUE (General tiredness) and VACCINATION SITE ERYTHEMA (The injection site was red for a while) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site erythema
Clinical narrative: The injection site was red for a while; Her arm hurt a little (L arm); Arm is swollen (L arm); Her armpits and the right arm began to hurt; Headache; Cold (chills); General tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Her arm hurt a little (L arm)), PERIPHERAL SWELLING (Arm is swollen (L arm)), AXILLARY PAIN (Her armpits and the right arm began to hurt), HEADACHE (Headache) and CHILLS (Cold (chills)) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMINS NOS for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced FATIGUE (General tiredness). On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (Her arm hurt a little (L arm)), PERIPHERAL SWELLING (Arm is swollen (L arm)), AXILLARY PAIN (Her armpits and the right arm began to hurt), HEADACHE (Headache) and CHILLS (Cold (chills)). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (The injection site was red for a while). At the time of the report, PAIN IN EXTREMITY (Her arm hurt a little (L arm)), PERIPHERAL SWELLING (Arm is swollen (L arm)), AXILLARY PAIN (Her armpits and the right arm began to hurt), HEADACHE (Headache), CHILLS (Cold (chills)), FATIGUE (General tiredness) and VACCINATION SITE ERYTHEMA (The injection site was red for a while) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Blood glucose fluctuation, Headache
Clinical narrative: blood glucose fluctuating; stomach upset; slight headache and went away; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE FLUCTUATION (blood glucose fluctuating), ABDOMINAL DISCOMFORT (stomach upset) and HEADACHE (slight headache and went away) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unkown) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included INSULIN ASPART (NOVOLOG), INSULIN GLARGINE (LANTUS), CLOPIDOGREL BISULFATE (PLAVIX), NIFEDIPINE, FUROSEMIDE, MECLIZINE HCL, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), POTASSIUM, 12 VITAMINS FOR INJECTION, FOLIC ACID, ALLOPURINOL, COLCHICINE and VITAMIN B COMPLEX for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach upset) and HEADACHE (slight headache and went away). On 10-Mar-2021, the patient experienced BLOOD GLUCOSE FLUCTUATION (blood glucose fluctuating). On 09-Mar-2021, HEADACHE (slight headache and went away) had resolved. At the time of the report, BLOOD GLUCOSE FLUCTUATION (blood glucose fluctuating) had not resolved and ABDOMINAL DISCOMFORT (stomach upset) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   Reporter did not allow further contact
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Over 42 days for the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Over 42 days for the second dose) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Over 42 days for the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Over 42 days for the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain in extremity, Rash macular, Wrong technique in device usage process
Clinical narrative: This spontaneous case was reported by a physician and describes the occurrence of WRONG TECHNIQUE IN DEVICE USAGE PROCESS (During administration of the vaccine the lady stuck the needle inside and after few minutes that was removed), PAIN IN EXTREMITY (Severe arm pain, right before his elbow up to his neck through his shoulder), RASH MACULAR (Hot spots), PAIN IN EXTREMITY (Intense pain in his arm and about 4 inch into the arm) and FATIGUE (Tiredness) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure and Diabetes. Concomitant products included WARFARIN SODIUM (COUMADIN) for an unknown indication.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced WRONG TECHNIQUE IN DEVICE USAGE PROCESS (During administration of the vaccine the lady stuck the needle inside and after few minutes that was removed). On 28-Feb-2021, the patient experienced PAIN IN EXTREMITY (Intense pain in his arm and about 4 inch into the arm), FATIGUE (Tiredness) and CHILLS (Chills). On 06-Mar-2021, the patient experienced PAIN IN EXTREMITY (Severe arm pain, right before his elbow up to his neck through his shoulder) and RASH MACULAR (Hot spots). The patient was treated with PARACETAMOL (TYLENOL 8 HR ARTHRITIS PAIN) at an unspecified dose and frequency and TRAMADOL at a dose of 50 mg. At the time of the report, WRONG TECHNIQUE IN DEVICE USAGE PROCESS (During administration of the vaccine the lady stuck the needle inside and after few minutes that was removed), PAIN IN EXTREMITY (Severe arm pain, right before his elbow up to his neck through his shoulder), RASH MACULAR (Hot spots), FATIGUE (Tiredness) and CHILLS (Chills) outcome was unknown and PAIN IN EXTREMITY (Intense pain in his arm and about 4 inch into the arm) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product used included blood pressure medications, diabetic medications and pain pill for treatment of pain.  The patient experienced intense pain which he never had in his life. He was taken to the emergency room and pain was so intense which lasted for 3hrs, then it stopped. Doctors have examined him and found nothing, told him nothing wrong and gave him pain pills. He took 2 of them and pain went away.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Follow-up SD added on 09-MAR-2021 updated event information and treatment information.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Menstrual disorder
Clinical narrative: Menstruation cycle stated two weeks early; Menstruation is painful; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUAL DISORDER (Menstruation cycle stated two weeks early) and DYSMENORRHOEA (Menstruation is painful) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 04L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was provided.).   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced MENSTRUAL DISORDER (Menstruation cycle stated two weeks early) and DYSMENORRHOEA (Menstruation is painful). At the time of the report, MENSTRUAL DISORDER (Menstruation cycle stated two weeks early) and DYSMENORRHOEA (Menstruation is painful) had resolved.            Concomitant products were not provided. Treatment products were not provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: contact info provided: email address
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: swelling near injection site; redness near injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling near injection site) and VACCINATION SITE ERYTHEMA (redness near injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swelling near injection site) and VACCINATION SITE ERYTHEMA (redness near injection site). At the time of the report, VACCINATION SITE SWELLING (swelling near injection site) and VACCINATION SITE ERYTHEMA (redness near injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No relevant concomitant medications were reported.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache
Clinical narrative: Headache; Left Hip Pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ARTHRALGIA (Left Hip Pain) and HEADACHE (Headache) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced ARTHRALGIA (Left Hip Pain). On 08-Mar-2021, the patient experienced HEADACHE (Headache). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PREGABALIN at an unspecified dose and frequency. At the time of the report, ARTHRALGIA (Left Hip Pain) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Patient was given Ibuprofen and Pregabalin by HCP to treat events. Patient had his second dose scheduled on 10-Mar-2021.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site rash
Clinical narrative: big red spot, (2 inches by 2 1/2 inches); little bit a sore arm; little red spot in the injection site.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little bit a sore arm), VACCINATION SITE ERYTHEMA (little red spot in the injection site.) and VACCINATION SITE RASH (big red spot, (2 inches by 2 1/2 inches)) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Blood pressure high, High cholesterol, Hypothyroidism and Anxiety. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (little bit a sore arm) and VACCINATION SITE ERYTHEMA (little red spot in the injection site.). On 10-Mar-2021, the patient experienced VACCINATION SITE RASH (big red spot, (2 inches by 2 1/2 inches)). At the time of the report, PAIN IN EXTREMITY (little bit a sore arm), VACCINATION SITE ERYTHEMA (little red spot in the injection site.) and VACCINATION SITE RASH (big red spot, (2 inches by 2 1/2 inches)) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in the arm). At the time of the report, PAIN IN EXTREMITY (pain in the arm) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information not reported.  Treatment information not provided by reporter.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain, Swelling
Clinical narrative: some aches; swelling; lymph node in her neck; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (some aches), SWELLING (swelling) and LYMPHADENOPATHY (lymph node in her neck) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 007M20A) for COVID-19 vaccination.     No medical history reported.  Concomitant products included SUMATRIPTAN for Migraine.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced PAIN (some aches), SWELLING (swelling) and LYMPHADENOPATHY (lymph node in her neck). At the time of the report, PAIN (some aches), SWELLING (swelling) and LYMPHADENOPATHY (lymph node in her neck) had not resolved. Not Provided          Treatment medications included  Medicine for migraine after shot.  On 4 March lymph node was bigger.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Abdominal pain upper, Decreased appetite, Vomiting
Clinical narrative: full blown stomach flu symptoms overnight; stomach ache; couldn't eat; puke evrytime; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISTENSION (full blown stomach flu symptoms overnight), ABDOMINAL PAIN UPPER (stomach ache), DECREASED APPETITE (couldn't eat) and VOMITING (puke evrytime) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cancer (NOS) (Patient was diagnosed with terminal cancer after receiving the first vaccine. She was not aware of this before receiving the vaccine.).    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced ABDOMINAL DISTENSION (full blown stomach flu symptoms overnight), ABDOMINAL PAIN UPPER (stomach ache), DECREASED APPETITE (couldn't eat) and VOMITING (puke evrytime). The patient was treated with DIMENHYDRINATE (DRAMAMINE) at an unspecified dose and frequency. At the time of the report, ABDOMINAL DISTENSION (full blown stomach flu symptoms overnight), ABDOMINAL PAIN UPPER (stomach ache), DECREASED APPETITE (couldn't eat) and VOMITING (puke evrytime) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided by the reporter.   Patient's son gave her some unspecified homeopathic nausea medications which did not helped her much with the symptoms. Then he gave her Dramamine.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Impaired healing
Clinical narrative: all across her lip and cheek, she has a dark red, round bruise; looks like a bruise that has been healing; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (all across her lip and cheek, she has a dark red, round bruise) and IMPAIRED HEALING (looks like a bruise that has been healing) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     The patient's past medical history included Lip augmentation (fillers in lips and cheeks.).    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced CONTUSION (all across her lip and cheek, she has a dark red, round bruise) and IMPAIRED HEALING (looks like a bruise that has been healing). At the time of the report, CONTUSION (all across her lip and cheek, she has a dark red, round bruise) was resolving and IMPAIRED HEALING (looks like a bruise that has been healing) had not resolved. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product used were not provided by the reporter.   Treatment medication were not reported by the reporter.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site pruritus, Injection site reaction
Clinical narrative: bump on the injection spot; itchy on the injection spot; injection site sore; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE REACTION (bump on the injection spot), INJECTION SITE PRURITUS (itchy on the injection spot) and INJECTION SITE PAIN (injection site sore) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Nasal disorder.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced INJECTION SITE REACTION (bump on the injection spot), INJECTION SITE PRURITUS (itchy on the injection spot) and INJECTION SITE PAIN (injection site sore). At the time of the report, INJECTION SITE REACTION (bump on the injection spot), INJECTION SITE PRURITUS (itchy on the injection spot) and INJECTION SITE PAIN (injection site sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       After three days of initial occurrence, the events they got better, then after 10 days the symptoms came back again.   Patient had a nostril problem for which she was taking unspecified anti fungal medication.   Patient used ice and anti itch cream to treat the symptoms.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Pain in extremity, Peripheral swelling, Pruritus, Rash
Clinical narrative: Around his neck lot of itching; His arm was puffy, warm and swollen; His arm was puffy, warm and swollen; Around his neck he had a very bad red rash; Arm hurt like crazy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt like crazy), PRURITUS (Around his neck lot of itching), PERIPHERAL SWELLING (His arm was puffy, warm and swollen), FEELING HOT (His arm was puffy, warm and swollen) and RASH (Around his neck he had a very bad red rash) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm hurt like crazy). On 07-Mar-2021, the patient experienced PRURITUS (Around his neck lot of itching), PERIPHERAL SWELLING (His arm was puffy, warm and swollen), FEELING HOT (His arm was puffy, warm and swollen) and RASH (Around his neck he had a very bad red rash). On 05-Mar-2021, PAIN IN EXTREMITY (Arm hurt like crazy) had resolved. At the time of the report, PRURITUS (Around his neck lot of itching), PERIPHERAL SWELLING (His arm was puffy, warm and swollen), FEELING HOT (His arm was puffy, warm and swollen) and RASH (Around his neck he had a very bad red rash) outcome was unknown. Not Provided          For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  No Concomitant medication was reported. No Treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow-up was received on 22-Jun-2021 contains Non- Significant Follow-up (  Reporter Email address was updated)